Figure 3.
Structures of prominent candidates for a (a) type I ½ and a (b) type II anaplastic lymphoma kinase inhibitor as presented in [7].
Structures of prominent candidates for a (a) type I ½ and a (b) type II anaplastic lymphoma kinase inhibitor as presented in [7].